Amgen to reduce expenditures by $1.9 billion and cut staff by 12-14 percent Barr second-quarter earnings show impressive jump from year-ago NACDS joins Rx Response program to coordinate care in times of severe emergency Eli Lilly looking to new blood-thinner to be best seller Euromonitor launches information system to measure ingredients in cosmetics FDA approves CV's Ranexa in increased-dosage tablet GSK receives FDA approvable letter for Requip CF Walgreens receives industry patient safety award Esprit pays milestone to Indevus, acquires marketing rights for Sanctura XR GSK, Takeda agree to add stronger warnings of heart failure to diabetes drug packaging First Previous 2730 2731 2732 2733 Next Last
